Myocardial infarction with acute coronary syndrome. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Interventions
Intervention 1: Intervention group: Enoxaparin 1 mg/kg subcutaneously every 12 hours in people over 75 years of age or with renal creatinine clearance less than 30 ml/min. In people under 75 years of
Treatment - Drugs
Intervention group: Enoxaparin 1 mg/kg subcutaneously every 12 hours in people over 75 years of age or with renal creatinine clearance less than 30 ml/min. In people under 75 years of age or with rena
Control group: In comparison with before intervention
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Age of 18 to 90 years myocardial infarction with acute coronary syndrome
Exclusion criteria
Exclusion criteria: Low blood platelet Heparin induced thrombocytopenia Uncontrolled hypertension Bacterial endocarditis Hemorrhagic stroke Gastric or duodenal ulcer Severe renal insufficiency Diabetic retinopathy Coagulation disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessing serum level of activated anti-factor XA. Timepoint: Before intervention and 12 hours after intervention. Method of measurement: Through laboratory test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Jila Hashemi
Hamedan University of Medical Sciences
Outcome results
None listed